Cargando…
Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models
Two key features of myeloma cells are the deregulation of the cell cycle and the dependency on the expression of the BCL2 family of anti-apoptotic proteins. The cell division cycle 7 (CDC7) is an essential S-phase kinase and emerging CDC7 inhibitors are effective in a variety of preclinical cancer m...
Autores principales: | Natoni, Alessandro, Coyne, Mark R. E., Jacobsen, Alan, Rainey, Michael D., O’Brien, Gemma, Healy, Sandra, Montagnoli, Alessia, Moll, Jürgen, O’Dwyer, Michael, Santocanale, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795371/ https://www.ncbi.nlm.nih.gov/pubmed/24202326 http://dx.doi.org/10.3390/cancers5030901 |
Ejemplares similares
-
A High Through-Put Screen for Small Molecules Modulating MCM2 Phosphorylation Identifies Ryuvidine as an Inducer of the DNA Damage Response
por: FitzGerald, Jennifer, et al.
Publicado: (2014) -
Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
por: O’ Reilly, Eimear, et al.
Publicado: (2018) -
Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation
por: Martin, Leenus, et al.
Publicado: (2011) -
Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
por: Natoni, Alessandro, et al.
Publicado: (2019) -
Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)